Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
(E/Z)Tamoxifen REF: 4Z-T-0121CAS: 7728-73-6	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 77 REF: 4Z-O-032083CAS: 2630919-53-6	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 74 REF: 4Z-O-032080CAS: 63964-50-1	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 24 REF: 4Z-C-121027CAS: 2049025-49-0	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 57 REF: 4Z-C-121060CAS: 254888-42-1	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 10 DiHCl REF: 4Z-O-032012CAS: 142-64-3	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 100 REF: 4Z-N-066114	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 46 REF: 4Z-C-121049	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 58 REF: 4Z-C-121061CAS: 1541171-68-9	- - -	To inquire	Tue 10 Dec 24
Leuprorelin (Leuprolide) EP Impurity J REF: 4Z-PL-4112	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 50 REF: 4Z-L-124057CAS: 2412398-76-4	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 97 REF: 4Z-N-066110CAS: 2097505-01-4	- - -	To inquire	Tue 10 Dec 24
O-Chlorobutylabiraterone REF: 4Z-A-8224	- - -	To inquire	Tue 10 Dec 24
Nintedanib-O-Methyl-13C-d3 (Intedanib-O-Methyl-13C-d3) REF: 4Z-N-066021	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 53 REF: 4Z-N-066071	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 39 REF: 4Z-P-196046CAS: 571189-65-6	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 6 REF: 4Z-F-3120	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 37 REF: 4Z-O-032042	- - -	To inquire	Tue 10 Dec 24
Tamoxifen EP Impurity H REF: 4Z-T-0119CAS: 809285-09-4	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 76 REF: 4Z-N-066087	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

(E/Z)Tamoxifen

Ref: 4Z-T-0121

Olaparib Impurity 77

Ref: 4Z-O-032083

Olaparib Impurity 74

Ref: 4Z-O-032080

Carfilzomib Impurity 24

Ref: 4Z-C-121027

Carfilzomib Impurity 57

Ref: 4Z-C-121060

Olaparib Impurity 10 DiHCl

Ref: 4Z-O-032012

Nintedanib Impurity 100

Ref: 4Z-N-066114

Carfilzomib Impurity 46

Ref: 4Z-C-121049

Carfilzomib Impurity 58

Ref: 4Z-C-121061

Leuprorelin (Leuprolide) EP Impurity J

Ref: 4Z-PL-4112

Lenvatinib Impurity 50

Ref: 4Z-L-124057

Nintedanib Impurity 97

Ref: 4Z-N-066110

O-Chlorobutylabiraterone

Ref: 4Z-A-8224

Nintedanib-O-Methyl-13C-d3 (Intedanib-O-Methyl-13C-d3)

Ref: 4Z-N-066021

Nintedanib Impurity 53

Ref: 4Z-N-066071

Palbociclib Impurity 39

Ref: 4Z-P-196046

Fulvestrant Impurity 6

Ref: 4Z-F-3120

Olaparib Impurity 37

Ref: 4Z-O-032042

Tamoxifen EP Impurity H

Ref: 4Z-T-0119

Nintedanib Impurity 76

Ref: 4Z-N-066087